Alto Neuroscience (ANRO) Earnings Date & Reports

Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individual's neurobiology to develop personalized and effective treatment options... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ANRO is expected to report earnings to rise 2.50% to -81 cents per share on November 11

Alto Neuroscience ANRO Stock Earnings Reports

Q3'26

Est.

$-0.82

Q1'26

Missed

by $0.12

Q4'25

Beat

by $0.20

Q3'25

Beat

by $0.12

Q2'25

Missed

by $0.05

The last earnings report on May 13 showed earnings per share of -80 cents, missing the estimate of -68 cents. With 291.17K shares outstanding, the current market capitalization sits at 1.35B.

View a ticker or compare two or three

ANRO

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days